Circular RNA hsa_circ_0005218 promotes the early recurrence of hepatocellular carcinoma by targeting the miR-31-5p/CDK1 pathway
Author:
Publisher
Elsevier BV
Subject
Multidisciplinary
Reference38 articles.
1. The clinical management of hepatocellular carcinoma worldwide: a concise review and comparison of current guidelines: 2022 update;Wen;Biosci. Trends,2022
2. Hepatocellular carcinoma;Llovet;Nat. Rev. Dis. Prim.,2021
3. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update;Reig;J. Hepatol.,2022
4. Systemic therapy for hepatocellular carcinoma: Chinese consensus-based interdisciplinary expert statements;Sun;Liver Canc.,2022
5. Characteristics and prognosis of patients with large well-differentiated hepatocellular carcinoma who have undergone resection;Lin;Am. J. Surg.,2022
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis;Frontiers in Immunology;2024-05-10
2. Comprehensive analysis of circRNA expression profiles in postmenopausal women differing in bone mineral density;Medicine;2024-04-19
3. Noncoding RNAs and programmed cell death in hepatocellular carcinoma: Significant role of epigenetic modifications in prognosis, chemoresistance, and tumor recurrence rate;Cell Biology International;2024-02-27
4. Transcriptomic sequencing analysis of key long noncoding RNAs and mRNAs expression profiles in postoperative recurrence of hepatocellular carcinoma;Technology and Health Care;2023-08-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3